» Articles » PMID: 32075688

Effect of Polymorphisms in Porcine Guanylate-binding Proteins on Host Resistance to PRRSV Infection in Experimentally Challenged Pigs

Overview
Journal Vet Res
Publisher Biomed Central
Date 2020 Feb 21
PMID 32075688
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Guanylate-binding proteins (GBP1 and GBP5) are known to be important for host resistance against porcine reproductive and respiratory syndrome virus (PRRSV) infection. In this study, the effects of polymorphisms in GBP1 (GBP1E2 and WUR) and GBP5 on host immune responses against PRRSV were investigated to elucidate the mechanisms governing increased resistance to this disease. Seventy-one pigs [pre-genotyped based on three SNP markers (GBP1E2, WUR, and GBP5)] were assigned to homozygous (n = 36) and heterozygous (n = 35) groups and challenged with the JA142 PRRSV strain. Another group of nineteen pigs was kept separately as a negative control group. Serum and peripheral blood mononuclear cells (PBMCs) were collected at 0, 3, 7, 14, 21 and 28 days post-challenge (dpc). Viremia and weight gain were measured in all pigs at each time point, and a flow cytometry analysis of PBMCs was performed to evaluate T cell activation. In addition, 15 pigs (5 pigs per homozygous, heterozygous and negative groups) were sacrificed at 3, 14 and 28 dpc, and the local T cell responses were evaluated in the lungs, bronchoalveolar lavage cells (BALc), lymph nodes and tonsils. The heterozygous pigs showed lower viral loads in the serum and lungs and higher weight gains than the homozygous pigs based on the area under the curve calculation. Consistently, compared with the homozygous pigs, the heterozygous pigs exhibited significantly higher levels of IFN-α in the serum, proliferation of various T cells (γδT, Th1, and Th17) in PBMCs and tissues, and cytotoxic T cells in the lungs and BALc. These results indicate that the higher resistance in the pigs heterozygous for the GBP1E2, WUR and GBP5 markers could be mediated by increased antiviral cytokine (IFN-α) production and T cell activation.

Citing Articles

Cell deconvolution-based integrated time-series network of whole blood transcriptome reveals systemic antiviral activities and cell-specific immunological changes against PRRSV infection.

Lim B, Lim C, Jang M, Seo Y, Kim D, Tuggle C Vet Res. 2025; 56(1):19.

PMID: 39844283 PMC: 11755918. DOI: 10.1186/s13567-025-01451-w.


Insights into genetic determinants of piglet survival during a PRRSV outbreak.

Tarres J, Jove-Junca T, Hernandez-Banque C, Gonzalez-Rodriguez O, Ganges L, Gol S Vet Res. 2024; 55(1):160.

PMID: 39696499 PMC: 11654192. DOI: 10.1186/s13567-024-01421-8.


Selection for Resilience in Livestock Production Systems.

Laghouaouta H, Fraile L, Pena R Int J Mol Sci. 2024; 25(23).

PMID: 39684818 PMC: 11641722. DOI: 10.3390/ijms252313109.


Capturing resilience from phenotypic deviations: a case study using feed consumption and whole genome data in pigs.

Mancin E, Maltecca C, Jiang J, Huang Y, Tiezzi F BMC Genomics. 2024; 25(1):1128.

PMID: 39574040 PMC: 11583387. DOI: 10.1186/s12864-024-11052-0.


Candidate markers for enhanced host response to PRRS have scarce adverse effects on pigs' growth and production.

Laghouaouta H, Fraile L, Estany J, Pena R Porcine Health Manag. 2024; 10(1):29.

PMID: 39169441 PMC: 11337565. DOI: 10.1186/s40813-024-00379-5.


References
1.
Pan W, Zuo X, Feng T, Shi X, Dai J . Guanylate-binding protein 1 participates in cellular antiviral response to dengue virus. Virol J. 2012; 9:292. PMC: 3520834. DOI: 10.1186/1743-422X-9-292. View

2.
Boddicker N, Bjorkquist A, Rowland R, Lunney J, Reecy J, Dekkers J . Genome-wide association and genomic prediction for host response to porcine reproductive and respiratory syndrome virus infection. Genet Sel Evol. 2014; 46:18. PMC: 3974599. DOI: 10.1186/1297-9686-46-18. View

3.
Kim H, Kwang J, Yoon I, Joo H, Frey M . Enhanced replication of porcine reproductive and respiratory syndrome (PRRS) virus in a homogeneous subpopulation of MA-104 cell line. Arch Virol. 1993; 133(3-4):477-83. DOI: 10.1007/BF01313785. View

4.
Excler J, Ake J, Robb M, Kim J, Plotkin S . Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccines. Clin Vaccine Immunol. 2014; 21(8):1023-36. PMC: 4135913. DOI: 10.1128/CVI.00230-14. View

5.
Opriessnig T, McKeown N, Harmon K, Meng X, Halbur P . Porcine circovirus type 2 infection decreases the efficacy of a modified live porcine reproductive and respiratory syndrome virus vaccine. Clin Vaccine Immunol. 2006; 13(8):923-9. PMC: 1539115. DOI: 10.1128/CVI.00074-06. View